Fairvalue-Calculator Fairvalue-Calculator
EN DE

DOD Biotech Public Company (DOD) Fair Value & Analysis

Consumer Defensive · TH · Market cap 730M THB

Price1.49 THB
Fair Value2.16 THB
Upside+45.0%
Quality95/100
Evidence: High Range 1.62 THB – 2.70 THB

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

DOD Biotech Public Company (DOD) currently trades at 1.49 THB, while our model-based Fair Value estimate is 2.16 THB — implying the stock looks roughly 45.0% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

DOD Biotech Public Company Limited, together with its subsidiaries, manufactures and distributes dietary supplements in Thailand. It offers dietary supplements for beauty and health in various forms comprising capsules, gels, jellies, powder, shot drinks, soft gels, tablets, probiotics, gummies, and direct-to-mouth. The company also provides food supplements and health drinks. In addition, it offers advisory, trading, and supplementary services; and research and development, design, FDA and HALAL registration, and consulting services. DOD Biotech Public Company Limited was incorporated in 2011 and is based in Mueang Samut Sakhon, Thailand.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is DOD Biotech Public Company (DOD) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 2.16 THB versus a price of 1.49 THB — about +45% (undervalued). Model-based estimate, not financial advice.
What is the fair value of DOD?
Our 21-model fair value for DOD Biotech Public Company is 2.16 THB (as of Jun 24, 2026), built from audited fundamentals. The current price is 1.49 THB.
What is the quality score of DOD?
DOD Biotech Public Company has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.